Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...

Photo by Maurice Ramirez Starting today, people with Parkinson’s disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology. The ...

New findings from scientists from the Carney Institute for Brian Science explain memory limits and shed light on ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Victor Dieriks receives funding from the Health Research Council Hercus Fellowship, the School of Medical Science, the University of Auckland and Te Tı̄ toki Mataora. Eden Paige Yin receives ...

Buspirone can interact with other drugs, including antidepressants, monoamine oxidase inhibitors, opioids, and more.

Working memory is what allows humans to juggle different pieces of information in short-term scenarios, like making a mental grocery list and then going shopping or remembering and then dialing a ...